Search - tctmd.com

Displaying 601 - 620 of 1214

Sort: Relevancy | Date

News Daily News

Prophylactic Anticoagulation, Fewer Deaths in Hospitalized COVID-19 Patients

Michael O'Riordan

February 15, 2021

News Daily News

FDA Approves Evinacumab for Rare Homozygous FH

Michael O'Riordan

February 11, 2021

News Features

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

Todd Neale

February 08, 2021

News Daily News

Primary PCI Underused but Just as Effective in Cancer Patients With STEMI

Michael O'Riordan

February 04, 2021

News Daily News

Rivaroxaban-Aspirin Combo Works in ASCVD Across BMI Groups

Todd Neale

February 01, 2021

News Opinion CV Team Dispatch

February 2021 News Roundup

L.A. McKeown

February 01, 2021

News Daily News

FDA Approves Vericiguat for High-risk Patients With HF

Michael O'Riordan

January 20, 2021

News Daily News

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

Michael O'Riordan

January 14, 2021

News Daily News

Stable CAD With High-Risk Anatomy Warrants PCI or CABG, APPROACH Suggests

Michael O'Riordan

January 05, 2021

News Daily News

ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show

Michael O'Riordan

December 21, 2020

News Features

Funding the Future: How Industry Support for CV Trials Could Evolve

Michael O'Riordan

December 17, 2020

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Features

Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good

Todd Neale

December 14, 2020

News Daily News

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Michael O'Riordan

December 11, 2020

News Daily News

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

Michael O'Riordan

December 07, 2020

News Daily News

Even Low-Dose Steroids Increase the Risk of CVD

Michael O'Riordan

December 03, 2020

News Features

Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI?

Michael O'Riordan

December 02, 2020

News Daily News

Colchicine in the Crosshairs for Its High US Cost

Caitlin E. Cox

December 01, 2020

News Daily News

Subjective Statin-Related AEs Have Been Rising; Hard Proof, Not So Much

Michael O'Riordan

November 26, 2020

News Conference News AHA 2020

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Michael O'Riordan

November 19, 2020

Advertisement

Prophylactic Anticoagulation, Fewer Deaths in Hospitalized COVID-19 Patients

FDA Approves Evinacumab for Rare Homozygous FH

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

Primary PCI Underused but Just as Effective in Cancer Patients With STEMI

Rivaroxaban-Aspirin Combo Works in ASCVD Across BMI Groups

February 2021 News Roundup

FDA Approves Vericiguat for High-risk Patients With HF

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

Stable CAD With High-Risk Anatomy Warrants PCI or CABG, APPROACH Suggests

ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show

Funding the Future: How Industry Support for CV Trials Could Evolve

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

Even Low-Dose Steroids Increase the Risk of CVD

Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI?

Colchicine in the Crosshairs for Its High US Cost

Subjective Statin-Related AEs Have Been Rising; Hard Proof, Not So Much

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content